These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23750345)

  • 1. Cytoplasmic globules in erythroid blasts and CLL.
    Jain P; Chen SS
    Blood; 2013 Apr; 121(17):3305. PubMed ID: 23750345
    [No Abstract]   [Full Text] [Related]  

  • 2. CLL with intra-cytoplasmic lymphocytic inclusion bodies.
    Badat M; Oyesanya F; Cervi P
    Int J Hematol; 2016 Oct; 104(4):411-2. PubMed ID: 27450076
    [No Abstract]   [Full Text] [Related]  

  • 3. Coexistence of myelodysplastic syndrome and untreated chronic lymphocytic leukemia with development of acute myeloid leukemia immediately after treatment of chronic lymphocytic leukemia.
    Bracey AW; Maddox AM; Immken L; Hsu SM; Marks ME
    Am J Hematol; 1989 Mar; 30(3):174-80. PubMed ID: 2916561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic leukemia].
    Shibata A; Narita M
    Gan To Kagaku Ryoho; 1989 May; 16(5):1982-8. PubMed ID: 2658837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auer rod-like inclusions in a low-grade B-cell leukemia.
    Hristov AC; Saladino A; Nava VE; Gocke CD
    Ann Diagn Pathol; 2010 Aug; 14(4):292-5. PubMed ID: 20637437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paving the road to MRD-guided treatment in CLL.
    Böttcher S
    Blood; 2014 Jun; 123(24):3683-4. PubMed ID: 24926065
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells.
    Santini V; Gozzini A; Scappini B; Caporale R; Zoccolante A; Rigacci L; Gelardi E; Grossi A; Alterini R; Ferrini PR
    Haematologica; 1999 Oct; 84(10):897-904. PubMed ID: 10509037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival among patients with chronic lymphocytic leukemia (CLL) treated in Department of Hematology, Medical University of Lublin.
    Sokołowska B; Wasik E; Kniaź M; Brzozowska J; Podhorecka M; Sledzińska M; Domański D
    Ann Univ Mariae Curie Sklodowska Med; 2000; 55():103-9. PubMed ID: 11482058
    [No Abstract]   [Full Text] [Related]  

  • 9. Approaches to Chronic Lymphocytic Leukemia Therapy in the Era of New Agents: The Conundrum of Many Options.
    Jain N; Thompson P; Ferrajoli A; Nabhan C; Mato AR; O'Brien S
    Am Soc Clin Oncol Educ Book; 2018 May; 38():580-591. PubMed ID: 30231393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idelalisib Bolsters CLL Regimen.
    Leslie M
    Cancer Discov; 2016 Mar; 6(3):OF2. PubMed ID: 26772993
    [No Abstract]   [Full Text] [Related]  

  • 11. Asymptomatic cauliflower ears in a 73-year-old man. Diagnosis: Leukemia cutis in the setting of indolent B-cell chronic lymphocytic leukemia (B-CLL).
    Kim PS; Sheth PB
    Arch Dermatol; 2011 Dec; 147(12):1443, 1448. PubMed ID: 22184770
    [No Abstract]   [Full Text] [Related]  

  • 12. Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Barrientos JC
    Future Oncol; 2016 Sep; 12(18):2077-94. PubMed ID: 27324214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease].
    Tumakov VA; Abdulkadyrov KM; Rugal' VI; Karpenkov MV; Ved' VV; Brodovskiĭ AF
    Klin Med (Mosk); 1991 Jan; 69(1):94-7. PubMed ID: 2023411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials.
    Soumerai JD; Ni A; Xing G; Huang J; Furman RR; Jones J; Sharman JP; Hallek M; Adewoye AH; Dubowy R; Dreiling L; Zelenetz AD
    Leuk Lymphoma; 2019 Jun; 60(6):1438-1446. PubMed ID: 30407886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukemia (CLL): first-line treatment.
    Hallek M;
    Hematology Am Soc Hematol Educ Program; 2005; ():285-91. PubMed ID: 16304393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
    Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
    Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia.
    Hallek M; Stahel RA; Greil R;
    Ann Oncol; 2005; 16 Suppl 1():i50-1. PubMed ID: 15888753
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of a patient with chronic lymphocytic leukaemia (CLL) presenting with bony metastases with aggressive antibody and chemotherapy.
    Narayan H; Bandyopadhyay D; Schmidt K; Chachlani N; Hughes M; Paneesha S; Rose P; Borg A
    Clin Lab Haematol; 2005 Dec; 27(6):405-8. PubMed ID: 16307545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia.
    Rodríguez CM; Stanganelli C; Bussi C; Arroyo D; Sastre D; Heller V; Iribarren P; Slavutsky I
    Leuk Lymphoma; 2018 May; 59(5):1239-1243. PubMed ID: 28868956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.